Royal Papworth Hospital NHS FT

Society for Cardiothoracic Surgery > Hospitals > Royal Papworth Hospital NHS FT

Introduction

Department of Cardiothoracic Surgery, Royal Papworth Hospital

About the unit

Royal Papworth Hospital is one of the largest specialist cardiothoracic (heart and lung) hospitals in Europe and includes the country’s main heart and lung transplant centre. Over the last three years, it has performed the highest number of heart surgery procedures in the UK whilst achieving some of the best outcomes with one of the lowest cardiac surgery mortality rates. Royal Papworth also provides a number of highly specialised services – we are one of only a number of centres who implant ventricular assist devices (VAD) and the only hospital in the UK offering Pulmonary Thromboendarterectomy (PEA) surgery.

Services provided

Adult Cardiac Surgery
Thoracic Surgery

Access

Several dedicated patient car parks with drop-off areas at the main entrance. Public transport availability to Royal Papworth is limited.

Visiting hours

Visits to wards and critical care areas are generally flexible but guidelines differ between wards.

Location

Royal Papworth Hospital Foundation Trust,
Papworth Everard,
Cambridge,
CB23 3RE

Tel: 01480 830541

Trust website:  https://royalpapworth.nhs.uk/

Cardiac Outcomes

Risk adjusted in-hospital survival rate

This graph shows the “in hospital” survival rate of patients who are operated on by the individual surgeon/unit you have selected. “In hospital” means time the patient is in the hospital where they have had their operation. It does not include any time that patients may have spent in other hospitals, either before or after their heart operation.

The data has been through a complex methodology, including the variations in patient risk factors in order to give you a comparative base from which to work from. This means that the survival rates take into account the type and risk of patients being operated on for each surgeon/unit. This is known as risk adjusted survival.

The vertical axis shows the GMC number of the surgeon or the Hospital identifier. In brackets is the total number of patients operated on by the surgeon/unit and the percentage of patients for whom the survival is known. The horizontal axis is the percentage survival. The dashed vertical line shows the risk adjusted survival rate for the UK as a whole. The solid black horizontal line represents the surgeon/unit. What is important here is that the horizontal line crosses the vertical dashed line. If this occurs, it means that the surgeon/unit are within the expected outcomes given the case-mix and risk factors of the patients they operate on.

The icons that sit on the horizontal line should give you more information about your surgeon/team.

For example

The open square is the survival rate with no risk adjustments:
The X is the predicted survival with adjustments
The solid dot is the survival probability after the methodology has been applied.

  • If the solid dot is red it means survival is worse than expected
  • If the solid dot is black it means that it is within limits
  • If the solid dot is green it means that there is significantly higher survival than expected

There is a lot of information on these plots, but the takeaway message is that if the solid black line crosses the dashed vertical line then the survival rate for the surgeon/unit is within expectations and that there is no reason for any concern.

A more detailed explanation about these graphs and methodology can be found here: Graph Explanations


Data for period April 2015 – March 2018.
Risk Adjusted In-Hospital Survival Rate

Thoracic Outcomes

The Lung Cancer Clinical Outcomes Publication or LCCOP 2019 (2017 data).

LCCOP is a compulsory audit of surgery for lung cancer in NHS hospitals in England. It does not cover SCTS units in the devolved nations or Ireland.

The outcomes of patients undergoing surgery to remove a lung cancer in this Trust in 2017 can be downloaded in PDF form here.

Several outcomes are reported. These are the percentage of patients alive at 30 days and one year after surgery, the median length of stay after surgery, the overall and the early stage performance status 0-1 resection rate for that unit.

Survival data are adjusted to take into account some of the characteristics for the patient population being treated.

Beside these numbers are the national data for England.

Surgeons operating in this hospital

Number of lung cancer operations
Coonar Aman Singh46
Peryt Adam58
Aresu Giuseppe73
(this table shows the names of the surgeons who performed lung cancer surgery in this hospital in 2017, and the number of operations they performed that year)

Other thoracic surgery undertaken by this team

Thoracic surgery units also undertake surgery for other cancers within the chest, such as thymoma or mesothelioma, and benign conditions like pneumothorax or pleural infections. The SCTS collects data on these other operations in the thoracic registry. Some data for this hospital for the 2017-18 audit year* is given below;

Data from the 2017-18 SCTS thoracic registry

Cases Performed
Total thoracic surgery excluding endoscopy all case (excluding endoscopy) 560
Did this hospital perform radical surgery for mesothelioma in 2017-18? No
Did this hospital perform chest wall deformity (pectus) surgery in 2017-18? Yes

*note that the thoracic registry reports in financial years (1st April-31st March), while the LCCOP audit reports in calendar year.

Consultant Cardiac Surgeons 2015 - 2018: 14

Consultant Congenital Cardiothoracic Surgeons: 0

Consultant Thoracic Surgeons 2017: 3

MENU